PDIAX | VIVIX | PDIAX / VIVIX | |
Total Expense Ratio | 0.98 | 0.04 | 2,450% |
Annual Report Gross Expense Ratio | 1.12 | 0.04 | 2,800% |
Fund Existence | 28 years | 27 years | - |
Gain YTD | 7.651 | 3.285 | 233% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 134M | 189B | 0% |
Annual Yield % from dividends | 2.71 | 2.29 | 118% |
Returns for 1 year | 13.87 | 8.89 | 156% |
Returns for 3 years | 20.84 | 33.27 | 63% |
Returns for 5 years | 18.40 | 73.96 | 25% |
Returns for 10 years | 18.99 | 105.19 | 18% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SRS | 47.93 | 0.86 | +1.83% |
ProShares UltraShort Real Estate | |||
SABA | 9.04 | 0.05 | +0.56% |
Saba Capital Income & Opportunities Fund II | |||
XBJA | 29.51 | -0.19 | -0.63% |
Innovator US Eq Acclrtd 9 Bffr ETF Jan | |||
IAK | 132.40 | -1.05 | -0.79% |
iShares US Insurance ETF | |||
ONEQ | 76.49 | -0.92 | -1.19% |
Fidelity Nasdaq Composite ETF |